|
Smolnova T.Yu., Trofimov D.Yu., Chuprynin V.D.
The role of tenascin gene (TNXB) mutation in Ellers-like phenotype formation in patients with genital prolapse
|
№6 / 2020
|
|
Mubarakshina O.A., Somova M.N., Batishcheva G.A., Peshekhonov D.V., Peshekhonov L.K.
Viscosupplementation of hyaluronic acid gels in case of osteoarthritis
|
№3 / 2020
|
|
Mazurov A.L., Trukhan D.I.
Chondroprotectors in integrated therapy of degenerativedystrophic changes of the support-motor apparatus
|
№2 / 2020
|
|
Davydov E.L., Trukhan D.I.
Patient with back pain at therapeutic acceptance: actual aspects of terminology, diagnostics and treatment
|
№2 / 2020
|
|
Ezhov I.Yu., Boyarshinov A.A, Glushkov A.E., Abramenkov A.N.
Combined use of chondroitin sulfate and hyaluronic acid for the treatment of arthrosis
|
№2 / 2019
|
|
A.A. Ktsoeva
The role of cartilaginous glycoprotein-39 in patients with knee osteoarthritis with concomitant coronary heart disease, arterial hypertension and dyslipidemia of unclear genesis - a multidisciplinary problem
|
№3 / 2018
|
|
Yu.A. Olyunin, N.Yu. Nikishina
Treatment of osteoarthritis. The main components of therapeutic complex
|
№4 / 2017
|
|
O.A. Gromova, I.Yu. Torshin, Ye.A. Dibrova, A.V. Gilels, B.I. Demidov
Human placenta hydrolyzates in reconstructive therapy of connective tissue of cartilage and joints
|
№6 / 2016
|
|
S.M. Noskov, T.A. Sherina, O.M. Parulya
The role of Alflutop in the treatment of primary osteoarthritis
|
№2 / 2016
|
Русский
